ALXN NASDAQ
Alexion Pharmaceuticals, Inc.
1W: -1.9%
1M: +1.0%
3M: +9.6%
1Y: +66.6%
3Y: +34.5%
5Y: +45.5%
$182.50
Last traded 2021-07-20 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$6B
Revenue
+18.2% YoY
$682M
Net Income
-71.3% YoY
$3B
Free Cash Flow
+37.9% YoY
92.3%
Gross Margin
38.9%
Op. Margin
38.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE5.6%
ROA3.7%
ROIC25.3%
Valuation
P/E66.4
P/B3.4
EV/EBITDA35.6
Leverage
Debt/Equity0.20
Current Ratio4.52
Interest Cov.5.8x
Quality Scores
Piotroski F8/9
Altman Z4.49
Beneish M-3.03